Skip to main content
Brian Na, MD, Pediatric Hematology & Oncology, San Francisco, CA

BrianNaMDPhD

Pediatric Hematology & Oncology San Francisco, CA

Cancer Genetics/Cancer Risk Assessment, Pediatric Neuro-Oncology

Pediatric and Adult Neuro-Oncology

Dr. Na is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Na's full profile

Already have an account?

  • Office

    400 Parnassus Avenue
    8th Floor
    San Francisco, CA 94143
    Phone+1 415-353-7500

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Neuro-Oncology, 2022 - 2024
  • UCLA
    UCLAPh.D., Molecular and Medical Pharmacology, 2020 - 2024
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 2018 - 2021
  • Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens Hospital
    Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 2015 - 2018
  • Drexel University College of Medicine
    Drexel University College of MedicineClass of 2015, MD

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2018 - 2025
  • OH State Medical License
    OH State Medical License 2015 - 2018
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Grant Support

  • Tower Cancer Research Foundation Career Development GrantTower Cancer Research Foundation2022–2023
  • Matthew Larson Iron Matt Foundation for Pediatric Brain TumorsIron Matt Foundation2022–2023
  • T32 Tumor Cell BiologyNIH2020–2022